Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rhinocort Aqua New Device vs Current vs Placebo in SAR
NCT00641979Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2002
- Primary completion
- Aug 2002
- Modality
- Orthosteric Ligands
01
Overview
Phase 2, randomised, double-blind trial of budesonide in seasonal allergic rhinitis (SAR) (3 arms), sponsored by AstraZeneca. Primary endpoint: Total Nasal Symptom Score. Started Apr 2002; status: completed.
02
Drugs
budesonide
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00641979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00641979.